Category: impact giving
Basic, discovery, validation and development research (preclinical research) are vital components of bringing new medical innovations to the people in need. These innovations include new medicines, vaccines, diagnostics and devices. The Conversation has recently published a good lay article describing the process of bringing a new medicine to market outlining the contents included in the […]VIEW POST
Measurements and rewards influence behaviour. They not only influence what is performed, but also what is not. Key performance indicators are often used to measure the performance of employees; they prioritise activities and drive behaviour. The measures, rewards and potential of future grant successes that funders of research and their employers put into the research […]VIEW POST
Australia’s innovation efficiency is a wicked problem needing a solution. The ability for Australia to capitalise on its research efforts has consistently ranked well below expectations. One of the key opportunities for philanthropy is to innovate and test solutions that can be scaled to assist in solving wicked problems such as this and contribute towards […]VIEW POST
I started writing this post to provoke a conversation and scratch the surface on an important issue. There are many differing points of view and most are valid, and less valid at the same time depending on the lens you are looking through. Measuring impact from research requires a more sophisticated or complex conversation than […]VIEW POST
Without caution evaluating grant applications and measuring impact can sometimes be like using an elastic tape measure.
The Age recently published an article ‘The dodgy academic journals publishing anti-vaxxers and other ‘crappy science’. The article describes a booming black market duping academics into submitting their research for a fee of up to $3000 a paper and notes the increasing number of reputable journals charging researchers to submit or cite their publications. We […]VIEW POST
Join a conversation with philanthropists, researchers, industry and government. Delivering impact from medical research.
In order to harness the benefits from medical research it is important to bring all key stakeholders together, including philanthropy, industry, government and academia. NFMRI’s conference uniquely provides this opportunity, creating an interactive forum to discuss opportunities, issues and ideas. We encourage delegates to submit questions in advance and contribute to the conversation. The […]VIEW POST
Professor Michael Good AO talks about NFMRI funding and his research into a new Strep vaccine for rheumatic heart disease and deep tissue infections The ‘Valley of Death’ grant that we recently received from the National Foundation for Medical Research and Innovation (NFMRI) has been a Godsend to our streptococcal vaccine project. Whist there […]VIEW POST
In the presence of industry, business and research experts and our partner representatives from the NSW Department of Primary Industries, on Wednesday 10 December we awarded our 2015 grants. This followed a recent strategy implementation that saw our Foundation change its focus towards advancing innovations and enabling collaborations, with funding available via competitive grants rounds […]VIEW POST
Assuming both are important where do you think priority should lie?VIEW POST
Australia excels in biomedical research but sucks at commercialisation. Professor Frank Gannon says that needs to change. This article, written by Graeme O’Neill, previously appeared in Lab + Life Scientist. Professor Gannon is director of the QIMR Berghofer Medical Research Institute, formerly known as the Queensland Institute of Medical Research. The institute is dedicated to […]VIEW POST